We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Edward Painter is the founder and CEO of A2A Pharmaceuticals Inc. At A2A, the mission is to leverage proprietary computational systems, including A.I., to accelerate development of novel drug alternatives for life threatening diseases like cancer, bacterial infections and muscular dystrophy.
Mr. Painter’s experience includes over 25 years investing in and helping life sciences as well as other technology companies raise capital with firms like Goldman Sachs and UBS.
This speaker's sessions: